Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
- PMID: 10348227
- DOI: 10.4269/ajtmh.1999.60.547
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives
Abstract
In prospective studies of acute uncomplicated, multidrug-resistant falciparum malaria on the western border of Thailand, the oral artemisinin derivatives were used alone in the treatment of 836 patients (artesunate 630, artemether 206), were combined with mefloquine (15-25 mg base/kg) in 2,826 patients, and mefloquine alone was used in 1,303 patients. The combined regimens of mefloquine plus an artemisinin derivative were associated with more side effects than those with an artemisinin derivative alone; acute nausea (31% versus 16%), vomiting (24% versus 11%), anorexia (51% versus 34%), and dizziness (47% versus 15%) (P < 0.001). Oral artesunate and artemether alone were very well tolerated. There was no difference in the incidence of possible adverse effects between the two drugs, and no evidence that either derivative caused allergic reactions, neurologic or psychiatric reactions, or cardiovascular or dermatologic toxicity. Blackwater fever occurred in three patients treated with mefloquine plus artesunate regimens. Oral artesunate and artemether are safe and well tolerated antimalarial drugs.
Similar articles
-
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.Malar J. 2005 Sep 22;4:46. doi: 10.1186/1475-2875-4-46. Malar J. 2005. PMID: 16179089 Free PMC article. Clinical Trial.
-
Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.Am J Trop Med Hyg. 2002 Nov;67(5):465-72. doi: 10.4269/ajtmh.2002.67.465. Am J Trop Med Hyg. 2002. PMID: 12479545 Clinical Trial.
-
Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.Trans R Soc Trop Med Hyg. 1995 Sep-Oct;89(5):523-7. doi: 10.1016/0035-9203(95)90094-2. Trans R Soc Trop Med Hyg. 1995. PMID: 8560531 Clinical Trial.
-
Overview of clinical studies on artemisinin derivatives in Thailand.Trans R Soc Trop Med Hyg. 1994 Jun;88 Suppl 1:S9-11. doi: 10.1016/0035-9203(94)90462-6. Trans R Soc Trop Med Hyg. 1994. PMID: 8053034 Review.
-
Use of artemisinin derivatives for the control of malaria.Med Trop (Mars). 1998;58(3 Suppl):45-9. Med Trop (Mars). 1998. PMID: 10212897 Review.
Cited by
-
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer.AAPS J. 2024 Aug 6;26(5):91. doi: 10.1208/s12248-024-00958-y. AAPS J. 2024. PMID: 39107504
-
Distribution patterns of molecular markers of antimalarial drug resistance in Plasmodium falciparum isolates on the Thai-Myanmar border during the periods of 1993-1998 and 2002-2008.BMC Genomics. 2024 Mar 11;25(1):269. doi: 10.1186/s12864-023-09814-3. BMC Genomics. 2024. PMID: 38468205 Free PMC article.
-
Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis.Nat Commun. 2024 Feb 3;15(1):1034. doi: 10.1038/s41467-024-45452-3. Nat Commun. 2024. PMID: 38310105 Free PMC article.
-
Molecular Interactions Identified by Two-Dimensional Analysis-Detailed Insight into the Molecular Interactions of the Antimalarial Artesunate with the Target Structure β-Hematin by Means of 2D Raman Correlation Spectroscopy.Anal Chem. 2023 Aug 29;95(34):12719-12731. doi: 10.1021/acs.analchem.3c01415. Epub 2023 Aug 16. Anal Chem. 2023. PMID: 37586701 Free PMC article.
-
Novel Therapeutics for Malaria.Pharmaceutics. 2023 Jun 23;15(7):1800. doi: 10.3390/pharmaceutics15071800. Pharmaceutics. 2023. PMID: 37513987 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources